# The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction

> **NCT02488005** · NA · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 15 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DEVICE:** Ultrasound

## Key facts

- **NCT ID:** NCT02488005
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2017-08-17
- **Final completion:** 2017-08-17
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02488005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02488005, "The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02488005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*